Steve Medlicott, the newly-appointed CFO of e-Therapeutics (LON:ETX) tells Proactive Investors the company has sufficient funds to support its development in the four years to come.
ETX surges on positive clinical data and appointment of Steve Medlicott
Quick facts: e-Therapeutics PLC
Price: 12.625 GBX
Market Cap: £53.12 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of e-Therapeutics PLC named herein, including the promotion by the Company of e-Therapeutics PLC in any Content on the Site, the Company receives...FOR OUR FULL DISCLAIMER CLICK HERE